These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33979562)

  • 21. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research.
    Cromwell J; Bartosch WJ; Fiore MC; Hasselblad V; Baker T
    JAMA; 1997 Dec; 278(21):1759-66. PubMed ID: 9388153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
    Evans WK; Gauvreau CL; Flanagan WM; Memon S; Yong JHE; Goffin JR; Fitzgerald NR; Wolfson M; Miller AB
    CMAJ Open; 2020; 8(3):E585-E592. PubMed ID: 32963023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD.
    Huber MB; Präger M; Coyle K; Coyle D; Lester-George A; Trapero-Bertran M; Nemeth B; Cheung KL; Stark R; Vogl M; Pokhrel S; Leidl R
    Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):52-64. PubMed ID: 29243347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of e-cigarettes compared with nicotine replacement therapy in stop smoking services in England (TEC study): a randomized controlled trial.
    Li J; Hajek P; Pesola F; Wu Q; Phillips-Waller A; Przulj D; Myers Smith K; Bisal N; Sasieni P; Dawkins L; Ross L; Goniewicz ML; McRobbie H; Parrott S
    Addiction; 2020 Mar; 115(3):507-517. PubMed ID: 31597207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of population-level proactive tobacco cessation outreach among socio-economically disadvantaged smokers: evaluation of a randomized control trial.
    Thao V; Nyman JA; Nelson DB; Joseph AM; Clothier B; Hammett PJ; Fu SS
    Addiction; 2019 Dec; 114(12):2206-2216. PubMed ID: 31483549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT.
    Taylor AH; Thompson TP; Streeter A; Chynoweth J; Snowsill T; Ingram W; Ussher M; Aveyard P; Murray RL; Harris T; Green C; Horrell J; Callaghan L; Greaves CJ; Price L; Cartwright L; Wilks J; Campbell S; Preece D; Creanor S
    Health Technol Assess; 2023 Mar; 27(4):1-277. PubMed ID: 37022933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of Financial Incentives for Patients and Physicians to Manage Low-Density Lipoprotein Cholesterol Levels.
    Pandya A; Asch DA; Volpp KG; Sy S; Troxel AB; Zhu J; Weinstein MC; Rosenthal MB; Gaziano TA
    JAMA Netw Open; 2018 Sep; 1(5):e182008. PubMed ID: 30646152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of personal tailored risk information and taster sessions to increase the uptake of the NHS stop smoking services: the Start2quit randomized controlled trial.
    Wu Q; Gilbert H; Nazareth I; Sutton S; Morris R; Petersen I; Galton S; Parrott S
    Addiction; 2018 Apr; 113(4):708-718. PubMed ID: 29105871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the cost-effectiveness of a high- and a low-intensity smoking cessation intervention in Sweden: a randomized trial.
    Nohlert E; Helgason AR; Tillgren P; Tegelberg A; Johansson P
    Nicotine Tob Res; 2013 Sep; 15(9):1519-27. PubMed ID: 23404735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop.
    Guerriero C; Cairns J; Roberts I; Rodgers A; Whittaker R; Free C
    Eur J Health Econ; 2013 Oct; 14(5):789-97. PubMed ID: 22961230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of computed tomography screening for lung cancer in the United States.
    McMahon PM; Kong CY; Bouzan C; Weinstein MC; Cipriano LE; Tramontano AC; Johnson BE; Weeks JC; Gazelle GS
    J Thorac Oncol; 2011 Nov; 6(11):1841-8. PubMed ID: 21892105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of financial incentives on top of behavioral support on quit rates in tobacco smoking employees: study protocol of a cluster-randomized trial.
    van den Brand FA; Nagelhout GE; Winkens B; Evers SM; Kotz D; Chavannes NH; van Schayck CP
    BMC Public Health; 2016 Oct; 16(1):1056. PubMed ID: 27716132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simulation-based estimates of effectiveness and cost-effectiveness of smoking cessation in patients with chronic obstructive pulmonary disease.
    Atsou K; Chouaid C; Hejblum G
    PLoS One; 2011; 6(9):e24870. PubMed ID: 21949774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
    Keating GM; Lyseng-Williamson KA
    Pharmacoeconomics; 2010; 28(3):231-54. PubMed ID: 20108995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic Impact of Financial Incentives and Mailing Nicotine Patches to Help Medicaid Smokers Quit Smoking: A Cost-Benefit Analysis.
    Sung HY; Penko J; Cummins SE; Max W; Zhu SH; Bibbins-Domingo K; Kohatsu ND
    Am J Prev Med; 2018 Dec; 55(6 Suppl 2):S148-S158. PubMed ID: 30454669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
    Feenstra TL; Hamberg-van Reenen HH; Hoogenveen RT; Rutten-van Mölken MP
    Value Health; 2005; 8(3):178-90. PubMed ID: 15877590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial of financial incentives for smoking cessation.
    Volpp KG; Gurmankin Levy A; Asch DA; Berlin JA; Murphy JJ; Gomez A; Sox H; Zhu J; Lerman C
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):12-8. PubMed ID: 16434580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PERSonalised Incentives for Supporting Tobacco cessation (PERSIST) among healthcare employees: a randomised controlled trial protocol.
    Boderie NW; van Kippersluis JL; Ó Ceallaigh DT; Radó MK; Burdorf A; van Lenthe FJ; Been JV
    BMJ Open; 2020 Sep; 10(9):e037799. PubMed ID: 32912952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic evaluation of an incentive-based program to increase physical activity and reduce sedentary behaviour in middle-aged adults.
    Maple JL; Ananthapavan J; Ball K; Teychenne M; Moodie M
    BMC Health Serv Res; 2022 Jul; 22(1):932. PubMed ID: 35854379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.